<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9607332</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20707</journal-id>
<journal-id journal-id-type="nlm-ta">Semin Cell Dev Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Semin. Cell Dev. Biol.</journal-id>
<journal-title-group>
<journal-title>Seminars in cell &amp; developmental biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1084-9521</issn>
<issn pub-type="epub">1096-3634</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26849906</article-id>
<article-id pub-id-type="pmc">6379054</article-id>
<article-id pub-id-type="doi">10.1016/j.semcdb.2016.01.040</article-id>
<article-id pub-id-type="manuscript">EMS81729</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tee</surname>
<given-names>Andrew R.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sampson</surname>
<given-names>Julian R.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pal</surname>
<given-names>Deb K.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bateman</surname>
<given-names>Joseph M.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Institute of Cancer &amp; Genetics, Cardiff University School of Medicine, Institute of Medical Genetics Building, Heath Park, Cardiff CF14 4XN UK</aff>
<aff id="A2">
<label>b</label>Department of Basic &amp; Clinical Neurosciences, Institute of Psychiatry, Psychology &amp; Neuroscience, King’s College, London SE5 8RX UK</aff>
<aff id="A3">
<label>c</label>Wolfson Centre for Age-Related Diseases, King’s College London, Guy’s Campus, London SE1 1UL UK</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Corresponding author. <email>joseph_matthew.bateman@kcl.ac.uk</email> (J.M. Bateman).</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>12</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>02</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>52</volume>
<fpage>12</fpage>
<lpage>20</lpage>
<!--elocation-id from pubmed: 10.1016/j.semcdb.2016.01.040-->
<abstract>
<p id="P1">Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the <italic>TSC1</italic> or <italic>TSC2</italic> gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases.</p>
</abstract>
<kwd-group>
<kwd>mTOR</kwd>
<kwd>Neuronal differentiation</kwd>
<kwd>Neuronal migration</kwd>
<kwd>Epilepsy</kwd>
<kwd>TSC</kwd>
<kwd>Neural stem cell</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>